ABCC7 p.Tyr89Cys
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 16126774
[PubMed]
Morea A et al: "Gender-sensitive association of CFTR gene mutations and 5T allele emerging from a large survey on infertility."
No.
Sentence
Comment
76
This test involved nine subjects from the infertile group, revealing the occurrence of the following rare mutations: E217G, T1054A, W356X, D443Y and 3667insTC in males and L997F and R297Q in females and 29 subjects from the control, in which we found: A1009T, D110Y, E826K, G1069R, G1130A, G194V, I556V, L320F, M348K, M82V, P1290T, R117C, R352W, R74W, S42F, S660T, S911R, S912L, T1086A, T582S, V920L and Y89C.
X
ABCC7 p.Tyr89Cys 16126774:76:407
status: NEW
PMID: 18306312
[PubMed]
Gene GG et al: "N-terminal CFTR missense variants severely affect the behavior of the CFTR chloride channel."
No.
Sentence
Comment
116
Moreover, some nascent/immature CFTR protein present in the ER and A B 501 E92K Y89C G85E/V P5L S50P E60K R75Q NBD1 NBD2 R FIGURE 1.
X
ABCC7 p.Tyr89Cys 18306312:116:80
status: NEW156 Confocal images from representative xy sections taken from1of 3 independent experiments show the subcellular distribution of wild-type CFTR (WT), p.F508del mutant (F508del), and variants p.S50P (S50P), p.E60K (E60K), p.G85E (G85E), p.G85V (G85V), p.E92K (E92K), p.P5L (P5L), p.R75Q (R75Q), and p.Y89C (Y89C).
X
ABCC7 p.Tyr89Cys 18306312:156:296
status: NEWX
ABCC7 p.Tyr89Cys 18306312:156:302
status: NEW182 C:Whole-cell currents evoked by variants p. R75Q (R75Q), p.P5L (P5L), and p.Y89C (Y89C).Wild-type CFTR current (WT) is also shown for comparison. Forskolin was applied for 90s.
X
ABCC7 p.Tyr89Cys 18306312:182:76
status: NEWX
ABCC7 p.Tyr89Cys 18306312:182:82
status: NEW3 By site-directed mutagenesis, we generated four CFTR variants in the N-terminal cytoplasmic tail (p.P5L, p.S50P, p.E60K, and p.R75Q) and four in the first transmembrane segment of membrane-spanning domain 1 (p.G85E/V, p.Y89C, and p.E92K).
X
ABCC7 p.Tyr89Cys 18306312:3:220
status: NEW6 In contrast, both p.R75Q and p.Y89C had a glycosylation pattern and a subcellular distribution comparable to the wild-type CFTR, while the percentage of mature p.P5L was considerably reduced, suggesting a major biogenesis flaw on this channel.
X
ABCC7 p.Tyr89Cys 18306312:6:31
status: NEW8 Single-channel patch-clamp analyses revealed that the channel activity of p.R75Q appeared similar to that of the wild-type CFTR, while both p.P5L and p.Y89C channels displayed abnormal gating.
X
ABCC7 p.Tyr89Cys 18306312:8:152
status: NEW40 The eight CFTR variants included in this study: p.P5L, p.S50P, p.E60 K, p.R75Q, p.G85E, p.G85V, p.Y89C, and p.E92K (Fig. 1A) were generated by oligonucleotide-directed mutagenesis in pCMVCFTRNot6.2wt using the QuickChangeTM XL-Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) according to the manufacturer`s instructions (see Supplementary Table S1 for a detailed description of the mutagenesis primers employed; available online at http://www.interscience.wiley.com/jpages/1059-7794/supp mat).
X
ABCC7 p.Tyr89Cys 18306312:40:98
status: NEW76 The average capacitances of HEK 293 cells transfected with wild-type CFTR and each of the three active channel variants were: wild-type CFTR (1671 pF; n 5 24); p.R75Q (2473 pF; n 5 18); p.Y89C (2072 pF; n 5 6); and p.P5L (2173 pF; n 5 20).
X
ABCC7 p.Tyr89Cys 18306312:76:188
status: NEW102 RESULTS Description and Cross-Species Analysis of Natural N-Terminus CFTR Variants We chose eight naturally occurring sequence variants, four located across the N-terminal CFTR tail (p.P5L, p.S50P, p.E60K, and p.R75Q), and four within the first segment of MSD1 (p.G85E, p.G85V, p.Y89C, and p.E92 K) (Fig. 1A; Table 1).
X
ABCC7 p.Tyr89Cys 18306312:102:280
status: NEW109 Some of the variants such as p.R75Q and p.Y89C, presented a glycosylation status comparable to the wild-type CFTR, suggesting that they might reach the PM.
X
ABCC7 p.Tyr89Cys 18306312:109:42
status: NEW118 B: Alignment of the N-terminus (amino acids 1 to 100) of the CFTR protein derived from di¡erent species.The sequences derived from human (Homo sapiens, Gen- BankNM_000492), mouse (Mus musculus,GenBankNM_021050), Norway rat (Rattusnovergicus,GenBankNM_031506), European rabbit (Oryctolagus cuniculus, GenBank NM_001082716), cow (Bos taurus, GenBank NM_174018), sheep (Ovis aries, GenBank NM_001009781), African clawed frog (Xenopus laevis, GenBank X65256), and spiny dog'sh (Squalus acanthias, GenBank M83785) were aligned using the ClustalW multiple sequence alignment program.The amino acid residue a¡ected by each of the variants analyzed (p.P5L, p.S50P, p.E60K, p.R75Q, p.G85E, p.G85V, p.Y89C, and p.E92K) is indicated in bold.
X
ABCC7 p.Tyr89Cys 18306312:118:701
status: NEW120 Likewise, variants p.R75Q and p.Y89C (Fig. 3) presented a localization pattern similar to that of wild-type CFTR, with most of the protein visualized in the PM (yellow colocalization of the merge images).
X
ABCC7 p.Tyr89Cys 18306312:120:32
status: NEW131 From the variants expressed in the PM (Fig. 3), only p.R75Q and p.Y89C generated cAMP-stimulated currents comparable to that of wild-type CFTR channel (Fig. 4C).
X
ABCC7 p.Tyr89Cys 18306312:131:66
status: NEW133 Genotype^Phenotype Correlation in the N-Terminal CFTR MissenseVariants Under Studyà Missense varianta Phenotype Second allele (number of patients)b p.P5L CF p.F508del (1), p.P205S (1) p.S50P CBAVD p.F508del (1), p.E115del (1) p.E60K CF p.G542X (1), p.I507del (1) p.R75Q HT p.F508del (3), p.E725K (1) B p.R347H (1), p.R75Q (1), n.i. (4) Br c.1584G4A (2), c.1210-7_1210-6delTT (1), n.i.(3) NT p.F508del (1) CP c.1584G4A (1), n.i. (3) MI n.i. (1) CUAVD n.i. (2) OZ n.i. (2) Normal p.R75Q (1), c.2052_2053insA (1), n.i. (1) p.G85E CF p.F508del (8), p.G542X (2), p.I507del (1), c.580-1G4T (1), p.G85E (1), c.1477_ 1478delCA (1) CBAVD p.G576A (1) HT p.L997F (1),WT (1) p.G85V CF p.F508del (2), p.G542X (2), p.Y1092X (1), c.265715G4A (1), p.A1006E, c.1210-7_1210- 6delTT (1), n.i. (1) p.Y89C CF n.i. (1)c p.E92K CF p.F508del (2), p.Q890X (1), p.L206W (1) CBAVD c.1210-7_1210-6delTT (1) ÃThe recommendations for mutation nomenclature (www.hgvs.org/mutnomen/) were used to name CFTR gene sequence variations at both the nucleotide level and the protein level.
X
ABCC7 p.Tyr89Cys 18306312:133:785
status: NEW151 Similar values were observed for p.R75Q (98755 pA/pF, n 5 18), and p.Y89C (114754 pA/pF, n 5 6), indicating that these CFTR variants were trafficked to the PM.
X
ABCC7 p.Tyr89Cys 18306312:151:69
status: NEW158 In the £uorescent images from variants p.P5L, p.R75Q, and p.Y89C, the contour plot from a successfully transfected cell, obtained from the corresponding phase contrast image, is shown to aid the identi'cation of the cell boundary.
X
ABCC7 p.Tyr89Cys 18306312:158:65
status: NEW166 Single-Channel Analysis of N-Terminus CFTR Variants Expressed at the Plasma Membrane To further investigate whether variants p.R75Q, and p.Y89C affected the chloride channel function of CFTR and, particularly, to delineate whether the reduced current density of p.P5L could be attributed only to a folding/trafficking defect or also to a channel malfunction, single-channel experiments were carried out.
X
ABCC7 p.Tyr89Cys 18306312:166:139
status: NEW197 As explained above, variants p.R75Q and p.Y89C were also able to reach the PM and supported chloride currents (Fig. 4).
X
ABCC7 p.Tyr89Cys 18306312:197:42
status: NEW199 Finally, the p.Y89C CFTR was at some extent, FIGURE 5.
X
ABCC7 p.Tyr89Cys 18306312:199:15
status: NEW213 Four of the variants (p.P5L, p.S50P, p.E60 K, and p.R75Q) are localized within the cytosolic N-terminal tail, and the remaining four (p.G85E, p.G85V, p.Y89C, and p.E92K) are embedded in three positions within the first transmembrane segment (TM1) of MSD1.
X
ABCC7 p.Tyr89Cys 18306312:213:152
status: NEW218 Conversely, we have observed that three CFTR missense variants, two (p.P5L and p.R75Q) located in the cytosolic N-terminus and one (p.Y89C) located within the first segment of MSD1, appeared to mature and reach the PM, albeit with different efficiencies.
X
ABCC7 p.Tyr89Cys 18306312:218:134
status: NEW228 Regarding the p.Y89C variant, based on the structural features of the amino acids involved (the bulky hydrophobic tyrosine residue is substituted by the smaller hydrophilic cysteine residue) and its position within TM1 (between the severe folding mutations p.G85E/V and p.E92K) it would also be expected a major structural rearrangement and folding defect of MSD1 conferred by this variant.
X
ABCC7 p.Tyr89Cys 18306312:228:16
status: NEW229 Surprisingly, p.Y89C CFTR was able to mature quite efficiently and to reach the PM.
X
ABCC7 p.Tyr89Cys 18306312:229:16
status: NEW232 Nevertheless, additional work is necessary to accurately define the electrophysiological properties of the p.Y89C variant.
X
ABCC7 p.Tyr89Cys 18306312:232:109
status: NEW255 Genotype^Phenotype Correlations All selected N-terminus CFTR missense variants except p.Y89C, described in an Italian patient [Padoan et al., 2000], have been identified in Spanish individuals with CF or different CFTR-related disorders (see Table 1 and references therein).
X
ABCC7 p.Tyr89Cys 18306312:255:88
status: NEW
No.
Sentence
Comment
64
Determination of the transepithelial nasal potential difference has been beneficial in establishing a CF Table 1 Mutations, sites, and molecular consequences associated with either an atypical presentation of CF respiratory disease or pancreatic sufficiency or late-onset pancreatic insufficiency (http:// www.genet.sickkids.on.ca) Mutation Site Consequence Atypical presentation M1210I Exon 19 Met to Ile at 1210 S1455X Exon 24 Ser to Stop at 1455 1811+18G→A Intron 11 mRNA splicing defect L346P Exon 7 Leu to Pro at 346 Y161D Exon 4 Tyr to Asp at 161 R31C Exon 2 Arg to Cys at 31 I752S Exon 13 Ile to Ser at 752 2811G/T Exon 15 Sequence variation Pancreatic sufficiency or late-onset pancreatic insufficiency R600G Exon 13 Arg to Gly at 600 D1152H Exon 18 Asp to His at 1152 Y89C Exon 3 Tyr to Cys at 89 R117H Exon 4 Arg to His at 117 D110E Exon 4 Asp to Glu at 110 296 + 3insT Intron 2 mRNA splicing defect E217G Exon 6a Glu to Gly at 217 V392G Exon 8 Val to Gly at 392 N1088D Exon 17b Asn to Asp at 1088 S737F Exon 13 Missense 1716+1G→A Intron 10 mRNA splicing defect R334W Exon 7 Arg to Trp at 334 R347P Exon 7 Arg to Pro at 347 A455E Exon 9 Ala to Glu at 455 P574H Exon 12 Pro to His at 574 3850-3T→G Intron 19 mRNA splicing defect diagnosis in many atypical cases.
X
ABCC7 p.Tyr89Cys 18493878:64:784
status: NEWX
ABCC7 p.Tyr89Cys 18493878:64:796
status: NEW